Evidence map›Paper›PMID 42459713›Full record

ArticleRSC advances2026

Novel seleno-ureido hybrids targeting head and neck cancer and beyond: design, synthesis, and apoptosis-mediated anticancer evaluation.

Saad Shaaban, Samia S Hawas, Ohud Alzaidi, Marwa Sharaky, Fatema S Alatawi, Khadra B Alomari, Zainab S Alghamdi, Hussein Ba-Ghazal, Arwa Omar Al Khatib, Hany M Abd El-Lateef and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Saad ShaabanDepartment of Chemistry, College of Science, King Faisal University Al-Ahsa 31982 Saudi Arabia sibrahim@kfu.edu.sa.ORCID https://orcid.org/0000-0002-7835-6926
Samia S HawasDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt New Damietta 34518 Egypt akarmalawy@horus.edu.eg.
Ohud AlzaidiDepartment of Chemistry, ‏College of Science-Al Khurma, Taif University Taif 21944 Saudi Arabia.
Marwa SharakyCancer Biology Department, National Cancer Institute (NCI), Cairo University Cairo Egypt.
Fatema S AlatawiDepartment of Biochemistry, Faculty of Science, University of Tabuk Tabuk Saudi Arabia.
Khadra B AlomariJazan University, Department of Physical Sciences, Chemistry Division Jazan 45142 Kingdom of Saudi Arabia.
Zainab S AlghamdiDepartment of Chemistry, College of Science, Imam Abdulrahman Bin Faisal University Dammam 31441 Saudi Arabia.
Hussein Ba-GhazalDepartment of Chemistry, College of Science, King Faisal University Al-Ahsa 31982 Saudi Arabia sibrahim@kfu.edu.sa.
Arwa Omar Al KhatibFaculty of Pharmacy, Al-Ahliyya Amman University Amman Jordan.
Hany M Abd El-LateefDepartment of Chemistry, College of Science, King Faisal University Al-Ahsa 31982 Saudi Arabia sibrahim@kfu.edu.sa.
Tarek A YousefCollege of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia.
Mohamed AlaasarDepartment of Chemistry, Faculty of Science, Cairo University Giza Egypt.
Ahmed A Al-KarmalawyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt New Damietta 34518 Egypt akarmalawy@horus.edu.eg.ORCID https://orcid.org/0000-0002-8173-6073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study systematically designed a series of urea-linked organoselenium hybrids

Identifiers

PMID42459713
PMCPMC13370745

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.